Glembotski Lab
Glembotski Lab
News
PI
People
Research
Career opportunities
Photo gallery
Publications
Contact
R. Luke Wiseman
Latest
Proteostasis and Beyond: ATF6 in Ischemic Disease.
Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis.
Pharmacologic ATF6 activating compounds are metabolically activated to selectively modify endoplasmic reticulum proteins.
Cite
×